Glycobiology of cell death: When glycans and lectins govern cell fate

Cell Death and Differentiation

Volumn 20, Issue 8, 2013, Pages 976-986

  Lichtenstein, R G ^a   Rabinovich, G A ^b,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apoptosis; Autophagy; Galectins; Glycans; Lectins

Indexed keywords

BETA1 INTEGRIN; BINDING PROTEIN; CARBOHYDRATE; CASPASE 3; CASPASE 9; CD45 ANTIGEN; DECTIN 1; ECALECTIN; FAS ANTIGEN; GALECTIN; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 7; GALECTIN 8; GLYCAN; LACTADHERIN; LECTIN; PADGEM PROTEIN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOPHAGY; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FATE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; APOPTOSIS; CELL DEATH; GLYCOSYLATION; HUMANS; LECTINS; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 84880276658     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.50     Document Type: Review

References (122)

1. Lockshin RA, Williams CM. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the pernyi silkmoth. J Insect Physiol 1965; 11: 123-133.
2. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
3. Sharon N, Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 2004; 14: 53R-62R.
4. Morris RG, Hargreaves AD, Duvall E, Wyllie AH. Hormone-induced cell death. 2 Surface changes in thymocytes undergoing apoptosis. Am J Pathol 1984; 115: 426-436.
5. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 1985; 56: 351-358.
6. Griffiths GD, Leek MD, Gee DJ. The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues and intestine. J Pathol 1987; 151: 221-229.
7. Wesselborg S, Kabelitz D. Activation-driven death of human T cell clones: time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death. Cell Immunol 1993; 148: 234-241.
8. Bu? ssing A, Suzart K, Bergmann J, Pfu? ller U, Schietzel M, Schweizer K. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 1996; 99: 59-72.
9. Fu LL, Zhou CC, Yao S, Yu JY, Liu B, Bao JK. Plant lectins: targeting programmed cell death pathways as antitumor agents. Int J Biochem Cell Biol 2011; 43: 1442-1449.
10. Rabinovich GA. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ 1999; 6: 711-721.
11. Rabinovich GA, Croci DO. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 2012; 36: 322-335.
12. Liu FT, Yang RY, Hsu DK. Galectins in acute and chronic inflammation. Ann N Y Acad Sci 2012; 1253: 80-91.
13. Brewer CF, Miceli MC, Baum LG. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol 2002; 12: 616-623.
14. Vasta GR. Galectins as pattern recognition receptors: structure, function, and evolution. Adv Exp Med Biol 2012; 946: 21-36.
15. Marth JD, Grewal PK. Mammalian glycosylation in immunity. Nat Rev Immunol 2008; 8: 874-887.
16. Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002; 12: 127R-136R.
17. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005; 5: 526-542.
18. Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 2007; 13: 1070-1077.
19. Moriwaki K, Noda K, Furukawa Y, Ohshima K, Uchiyama A, Nakagawa T et al. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 2009; 137: 188-198.
20. Moriwaki K, Shinzaki S, Miyoshi E. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation. J Biol Chem 2011; 286: 43123-43133.
21. Shatnyeva OM, Kubarenko AV, Weber CE, Pappa A, Schwartz-Albiez R, Weber AN et al. Modulation of the CD95-induced apoptosis: the role of CD95 N-glycosylation. PLoS One 2011; 6: e19927.
22. Charlier E, Condé C, Zhang J, Deneubourg L, Di Valentin E, Rahmouni S et al. SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia 2010; 24: 821-832.
23. Dall'Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J 2001; 18: 841-850.
24. Peter ME, Hellbardt S, Schwartz-Albiez R, Westendorp MO, Walczak H, Moldenhauer G et al. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ 1995; 2: 163-171.
25. Keppler OT, Peter ME, Hinderlich S, Moldenhauer G, Stehling P, Schmitz I et al. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 1999; 9: 557-569.
26. Swindall AF, Bellis SL. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem 2011; 286: 22982-22990.
27. Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Terskikh A et al. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J Biol Chem 1997; 272: 18827-18833.
28. Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res 2003; 63: 5573-5581.
29. Rabinovich GA, Ilarregui JM. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol Rev 2009; 230: 144-159.
30. Matarrese P, Tinari A, Mormone E, Bianco GA, Toscano MA, Ascione B et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem 2005; 280: 6969-6985.
31. Liu Z, Swindall AF, Kesterson RA, Schoeb TR, Bullard DC, Bellis SL. ST6Gal-I regulates macrophage apoptosis via a2-6 sialylation of the TNFR1 death receptor. J Biol Chem 2011; 286: 39654-3962.
32. Fukumori T, Takenaka Y, Oka N, Yoshii T, Hogan V, Inohara H et al. Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res 2004; 64: 3376-3379.
33. Oka N, Nakahara S, Takenaka Y, Fukumori T, Hogan V, Kanayama HO et al. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. Cancer Res 2005; 65: 7546-7553.
34. Lee YJ, Song YK, Song JJ, Siervo-Sassi RR, Kim HR, Li L et al. Reconstitution of galectin-3 alters glutathione content and potentiates TRAIL-induced cytotoxicity by dephosphorylation of Akt. Exp Cell Res 2003; 288: 21-34.
35. Wells V, Mallucci L. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death. Breast Cancer Res 2009; 11: R2.
36. Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J et al. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ 2012; 19: 523-533.
37. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS. Phosphorylation of the betagalactoside- binding protein galectin-3 modulates binding to its ligands. J Biol Chem 2000; 275: 36311-36315.
38. Mazurek N, Sun YJ, Liu KF, Gilcrease MZ, Schober W, Nangia-Makker P et al. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem 2007; 282: 21337-21348.
39. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999; 163: 3801-3811.
40. Desharnais P, Dupéré -Minier G, Hamelin C, Devine P, Bernier J. Involvement of CD45 in DNA fragmentation in apoptosis induced by mitochondrial perturbing agents. Apoptosis 2008; 13: 197-212.
41. Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, Kier-Joffé EB et al. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and nonapoptotic mechanisms. Cell Death Differ 2002; 9: 661-670.
42. Hahn HP, Pang M, He J, Hernandez JD, Yang RY, Li LY et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 2004; 11: 1277-1286.
43. Ion G, Fajka-Boja R, Tó th GK, Caron M, Monostori E. Role of p56lck and ZAP70- mediated tyrosine phosphorylation in galectin-1-induced cell death. Cell Death Differ 2005; 12: 1145-1147.
44. Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Differ 2000; 7: 747-753.
45. Brandt B, Abou-Eladab EF, Tiedge M, Walzel H. Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death. Cell Death Dis 2010; 1: e23.
46. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN et al. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 2001; 167: 5697-5707.
47. Earl LA, Bi S, Baum LG. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem 2010; 285: 2232-2244.
48. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 2007; 8: 825-834.
49. Fulcher JA, Chang MH, Wang S, Almazan T, Hashimi ST, Eriksson AU et al. Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. J Biol Chem 2009; 284: 26860-26870.
50. Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF et al. Galectin-1 deactivates classically activated microglia and protects from inflammationinduced neurodegeneration. Immunity 2012; 37: 249-263.
51. Van Dyken SJ, Green RS, Marth JD. Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis. Mol Cell Biol 2007; 27: 1096-1111.
52. Van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 2006; 7: 1200-1208.
53. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 2003; 63: 8302-8311.
54. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 2006; 176: 778-789.
55. Yu F, Finley RL Jr, Raz A, Kim HR. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 2002; 277: 15819-15827.
56. Zhuo Y, Chammas R, Bellis SL. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem 2008; 283: 22177-22185.
57. Cohen M, Elkabets M, Perlmutter M, Porgador A, Voronov E, Apte RN et al. Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. J Immunol 2010; 185: 5869-5878.
58. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol 2007; 179: 1225-1235.
59. Rabinovich GA, Toscano MA. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009; 9: 338-352.
60. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245-1252.
61. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003; 170: 3631-3636.
62. Lu LH, Nakagawa R, Kashio Y, Ito A, Shoji H, Nishi N et al. Characterization of galectin-9- induced death of Jurkat T cells. J Biochem 2007; 141: 157-172.
63. Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 2012; 18: 1394-1400.
64. Cao E, Zang X, Ramagopal UA, Mukhopadhaya A, Fedorov A, Fedorov E et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 2007; 26: 311-321.
65. Gupta S, Thornley TB, Gao W, Larocca R, Turka LA, Kuchroo VK et al. Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs. J Clin Invest 2012; 122: 2395-2404.
66. Sturm A, Lensch M, André S, Kaltner H, Wiedenmann B, Rosewicz S et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004; 173: 3825-3837.
67. Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One 2008; 3: e2629.
68. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752.
69. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 2002; 277: 3487-3497.
70. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 1999; 96: 11329-1134.
71. Villeneuve C, Baricault L, Canelle L, Barboule N, Racca C, Monsarrat B et al. Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells. Mol Biol Cell 2011; 22: 999-1013.
72. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996; 93: 6737-6742.
73. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
74. Li X, Ma Q, Wang J, Liu X, Yang Y, Zhao H et al. c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. Cell Death Differ 2010; 17: 1277-1287.
75. Yogalingam G, Pendergast AM. Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem 2008; 283: 35941-35953.
76. Hutchins MU, Klionsky DJ. Vacuolar localization of oligomeric alpha-mannosidase requires the cytoplasm to vacuole targeting and autophagy pathway components in Saccharomyces cerevisiae. J Biol Chem 2001; 276: 20491-20498.
77. Suzuki K, Kondo C, Morimoto M, Ohsumi Y. Selective transport of alpha-mannosidase by autophagic pathways: identification of a novel receptor, Atg34p. J Biol Chem 2010; 285: 30019-30025.
78. Watanabe Y, Noda NN, Kumeta H, Suzuki K, Ohsumi Y, Inagaki F. Selective transport of alpha-mannosidase by autophagic pathways: structural basis for cargo recognition by Atg19 and Atg34. J Biol Chem 2010; 285: 30026-30033.
79. Gabel CA, Goldberg DE, Kornfeld S. Lysosomal enzyme oligosaccharide phosphorylation in mouse lymphoma cells: specificity and kinetics of binding to the mannose 6-phosphate receptor in vivo. J Cell Biol 1982; 95: 536-542.
80. Kollmann K, Damme M, Markmann S, Morelle W, Schweizer M, Hermans-Borgmeyer I et al. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain 2012; 135: 2661-2675.
81. Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 2012; 482: 414-418.
82. Li S, Wandel MP, Li F, Liu Z, He C, Wu J et al. Sterical hindrance promotes selectivity of the autophagy cargo receptor NDP52 for the danger receptor galectin-8 in antibacterial autophagy. Sci Signal 2013; 6: ra9.
83. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 2003; 299: 1397-1400.
84. Oda Y, Hosokawa N, Wada I, Nagata K. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 2003; 299: 1394-1397.
85. Gu F, Nguyên DT, Stuible M, Dubé N, Tremblay ML, Chevet E. Protein-tyrosine phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress. J Biol Chem 2004; 279: 49689-49693.
86. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007; 318: 944-949.
87. Lazar C, Macovei A, Petrescu S, Branza-Nichita N. Activation of ERAD pathway by human hepatitis B virus modulates viral and subviral particle production. PLoS One 2012; 7: e34169.
88. Smits P, Bolton AD, Funari V, Hong M, Boyden ED, Lu L et al. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med 2010; 362: 206-216.
89. Barr FA, Short B. Golgins in the structure and dynamics of the Golgi apparatus. Curr Opin Cell Biol 2003; 15: 405-413.
90. Maag RS, Mancini M, Rosen A, Machamer CE. Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. Mol Biol Cell 2005; 16: 3019-3027.
91. Mukherjee S, Chiu R, Leung SM, Shields D. Fragmentation of the Golgi apparatus: an early apoptotic event independent of the cytoskeleton. Traffic 2007; 8: 369-378.
92. Lauber K, Bohn E, Kro?ber SM, Xiao YJ, Blumenthal SG, Lindemann RK et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717-730.
93. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000; 165: 2156-2164.
94. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003; 112: 3893-3897.
95. Fernández GC, Ilarregui JM, Rubel CJ, Toscano MA, Gómez SA, Beigier Bompadre M et al. Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 2005; 15: 519-527.
96. Bournazou I, Pound JD, Duffin R, Bournazos S, Melville LA, Brown SB et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest 2009; 119: 20-32.
97. Britigan BE, Serody JS, Hayek MB, Charniga LM, Cohen MS. Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation. J Immunol 1991; 147: 4271-4277.
98. Shiratsuchi A, Watanabe I, Ju JS, Lee BL, Nakanishi Y. Bridging effect of recombinant human mannose-binding lectin in macrophage phagocytosis of Escherichia coli. Immunology 2008; 124: 575-583.
99. Schagat TL, Wofford JA, Wright Jr. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 2001; 166: 2727-2733.
100. Litvack ML, Palaniyar N. Review: soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. Innate Immun 2010; 16: 191-200.
101. Caberoy NB, Alvarado G, Bigcas JL, Li W. Galectin-3 is a new MerTK-specific eat-me signal. J Cell Physiol 2012; 227: 401-407.
102. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 2003; 278: 41282-41293.
103. Stowell SR, Arthur CM, Slanina KA, Horton JR, Smith DF, Cummings RD. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 2008; 283: 20547-20559.
104. Stowell SR, Karmakar S, Arthur CM, Ju T, Rodrigues LC, Riul TB et al. Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol Biol Cell 2009; 20: 1408-1418.
105. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 1998; 5: 551-562.
106. Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003; 4: 587-598.
107. Maugeri N, Rovere-Querini P, Evangelista V, Covino C, Capobianco A, Bertilaccio MT et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 2009; 113: 5254-5265.
108. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417: 182-187.
109. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150.
110. Toda S, Hanayama R, Nagata S. Two-step engulfment of apoptotic cells. Mol Cell Biol 2012; 32: 118-125.
111. Pang M, He J, Johnson P, Baum LG. CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells. J Immunol 2009; 182: 7001-7008.
112. Watanabe Y, Shiratsuchi A, Shimizu K, Takizawa T, Nakanishi Y. Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages. J Biol Chem 2002; 277: 18222-18228.
113. Meesmann HM, Fehr EM, Kierschke S, Herrmann M, Bilyy R, Heyder P et al. Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. J Cell Sci 2010; 123: 3347-3356.
114. Rapoport E, Khaidukov S, Baidina O, Bojenko V, Moiseeva E, Pasynina G et al. Involvement of the Galbeta1-3GalNAcbeta structure in the recognition of apoptotic bodies by THP-1 cells. Eur J Cell Biol 2003; 82: 295-302.
115. Eda S, Yamanaka M, Beppu M. Carbohydrate-mediated phagocytic recognition of early apoptotic cells undergoing transient capping of CD43 glycoprotein. J Biol Chem 2004; 279: 5967-5974.
116. Ise H, Goto M, Komura K, Akaike T. Engulfment and clearance of apoptotic cells based on a GlcNAc-binding lectin-like property of surface vimentin. Glycobiology 2012; 22: 788-805.
117. Rapoport EM, Sapot'ko YB, Pazynina GV, Bojenko VK, Bovin NV. Sialoside-binding macrophage lectins in phagocytosis of apoptotic bodies. Biochemistry (Mosc) 2005; 70: 330-338.
118. Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Gru?nebach F et al. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2008; 111: 4264-4272.
119. Carlin AF, Chang YC, Areschoug T, Lindahl G, Hurtado-Ziola N, King CC et al. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med 2009; 206: 1691-1699.
120. Wang Y, Neumann H. Alleviation of neurotoxicity by microglial human Siglec-11. J Neurosci 2010; 30: 3482-3488.
121. Paessens LC, Fluitsma DM, van Kooyk Y. Haematopoietic antigen-presenting cells in the human thymic cortex: evidence for a role in selection and removal of apoptotic thymocytes. J Pathol 2008; 214: 96-103.
122. Majai G, Gogolák P, Ambrus C, Vereb G, Hodrea J, Fésu?s L et al. PPARg modulated inflammatory response of human dendritic cell subsets to engulfed apoptotic neutrophils. J Leukoc Biol 2010; 88: 981-991.